Registry in Korea: BioMimeTM Stent, Ultimaster® Stent vs. Xience® Stent

NCT02986295 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2018-02-09

No results posted yet for this study

Summary

Comparison of safety and long-term effects of BioMimeTM stent and Ultimaster® stent with Xience® stent

Conditions

  • Ischemic Heart Disease

Interventions

DEVICE

BioMimeTM Stent, Ultimaster® Stent

Sponsors & Collaborators

  • Meril Life Sciences Pvt. Ltd.

    collaborator INDUSTRY
  • Terumo Corporation

    collaborator INDUSTRY
  • Hyeon-Cheol Gwon

    lead OTHER

Principal Investigators

  • Hyeon Cheol Gwon · Samsung Medical Center

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-01
Primary Completion
2019-01-31
Completion
2021-01-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02986295 on ClinicalTrials.gov